KBC Securities - Biotalys NV (BTLS) Morning Note: BTLS BB

Report

KBC Securities

Guy Sips

Morning Note: BTLS BB

Biotalys: Shaping future of sustainable and safe food supply

16/08/2021 1 EN

Underlying

Biotalys NV

See profile

Provider

KBC Securities

We are a financial services provider for several types of professional clients, each with distinct needs.

See profile

Analysts

Guy Sips

Other Reports on these Companies

KBC Securities

Morning Note: AZE BB, BTLS BB, MITRA BB, Telecom BE

Azelis: Expansion into South America Biotalys: Partnership with Novozymes for Evoca Mithra: Additional details on private placement Telecom: Results mobile spectrum auction

June 21, 2022 June 21, 2022 1 EN

KBC Securities

KBCS New Horizon Conference Book AGFB BB, ARCAD NA, ASML NA, BAR BB, BTLS BB, DIE BB, EKOP BB, HYL BB, IBAB BB, MITRA BB, TWEKA NA

On Thursday 9 June, we organise our first New Horizon Conference in London. Following listed companies will be presented: • ASML • Agfa • Arcadis • Barco • Biotalys • D'Ieteren • Ebusco • Ekopak • Hyloris • IBA • Mithra • TKH We give a summary of our view on the companies we welcome, with key investment metrics that can serve as a guide during your meeting(s).

June 7, 2022 June 7, 2022 1 EN

KBC Securities

Morning Note: ASC BB, AZE BB, BTLS BB, COFB BB, EKOP BB

Ascencio: 1H21/22 Slightly ahead of expectations Azelis: Initiation - Formula for success, at a price Biotalys: BioProtection Award 2022 for Best Biofungicide Cofinimmo: Clearing out the old Offices Ekopak: Update on roll-out in France Various: Coverage update

May 25, 2022 May 25, 2022 1 EN

Sequana Medical Extends runway into 1Q26 with additional € 6.3m convertible loan

Sequana announced that SFPIM and other existing shareholders have invested a further € 6.3m in the 2025 convertible loan announced on 18 March 2025. Sequana's cash runway has now been extended into 1Q26 (previously YE25), which will provide Sequana with more breathing room to demonstrate initial commercial traction during the soft launch phase of the alfapump's US commercialisation in 3Q25. This could trigger additional investor interest to fund the company into the broader launch, which is expected in 2Q26. We reiterate our € 5 TP and Buy rating.

13h / 29m 13h / 29m 1 EN

Jacob Mekhael ... (+2)

Jacob Mekhael
Thomas Couvreur

Morning Notes : NN NA, SEQUA BB

: NN NA, SEQUA BB

13h / 37m 13h / 37m 1 EN

Thomas Vranken

Thomas Vranken

Dynamic Top Pick List update Removing Merus

Last week, Merus announced solid interim Phase 2 data to be presented at the ASCO 2025 conference with its lead asset petosemtamab in combination with current standard of care Keytruda for first-line treatment of patients with head and neck cancer (PD-L1+ refractory/ metastatic (r/m) head and neck squamous cell carcinoma (HNSCC)), a cancer type that is notoriously hard to treat. The updated dataset contains more patients than last year's presentation and featured a 63% overall response rate (27/43 patients), of which 6 were complete responses. The median progression-free survival of treated pa...

14h / 5m 14h / 5m 1 EN

Sign-up for free to access full reports immediately

Email Address*

Choose Password* ( 6 or more characters )

Due to regulatory restrictions regarding the distribution of financial research, this report is restricted to a specific region or investor type. Get access to exclusive reports by answering the questions below.

Select your country*

Get financial insights straight to your inbox

By clicking "register" you accept the Terms and Conditions & Privacy Policy

Already on ResearchPool?

Almost there...

Are you a professional investor?

Select your country

REGISTER

Create a free ResearchPool account to access full reports, get a personalised dashboard and follow providers or companies

In order to access this report please create an account.

LOGIN

Morning Note: BTLS BB

We are a financial services provider for several types of professional clients, each with distinct needs.

Morning Note: AZE BB, BTLS BB, MITRA BB, Telecom BE

KBCS New Horizon Conference Book AGFB BB, ARCAD NA, ASML NA, BAR BB, BTLS BB, DIE BB, EKOP BB, HYL BB, IBAB BB, MITRA BB, TWEKA NA

Morning Note: ASC BB, AZE BB, BTLS BB, COFB BB, EKOP BB

Sequana Medical Extends runway into 1Q26 with additional € 6.3m convertible loan

Morning Notes : NN NA, SEQUA BB

Dynamic Top Pick List update Removing Merus

Create a free ResearchPool account to access full reports, get a personalised dashboard and follow providers or companies

Sign-up for free to access full reports immediately

ResearchPool Subscriptions

Get the most out of your insights

Why subscribe?

How to subscribe

ResearchPool Subscriptions

This report is only available to subscribers

Why subscribe?

How to subscribe